Home | Contact Us | Log In
(888) 789-6604
Report Stack
Advanced search
Account Detail 0 items in basket
Order History Total $
Saved Searches View Basket basket
United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017-2022
Publication Date May 2017
Product Type Report
Pages 110
Single User License help $ 990.00
Site User License help $ 1490.00
Corporate User License help $ 1490.00
 

Reportstack.com does not charge credit card fee, transaction charges, extra tax or VAT on any purchase.

"United States Blood Glucose Meter Market is likely to reach USD 650 Million by the year end of 2022.

Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes mellitus, improved glucose control and flexible, user–friendly design, government efforts for better management of diabetes mellitus and technological advancement in blood glucose meter devices.

The research report titled “United States Blood Glucose Meter Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Blood Glucose Meter Market. The study provides an in–depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. Moreover, it also provides an essential insight on insulin users.  

The report provides a decisive view on the Blood Glucose Meter Users and Market. It also covers reimbursement pattern and offers a clear view of the regulatory landscape in the United States Blood Glucose Meter Market. Key trends in terms of collaboration, partnership, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Blood Glucose Meter Market. The report concludes with the profiles of major players in the United States Blood Glucose Meter Market. The key market players are evaluated on various parameters such as company overview, marketed products and latest development and trends of the Blood Glucose Meter Market.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• Insulin Users (2011 – 2022)
• United States Blood Glucose Meter Users and Market Analysis (2011 – 2022)
• United States Blood Glucose Meter Market: Reimbursement & Regulation System
• United States Blood Glucose Meter Market – Major Deal Types
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Blood Glucose Meter Market

Key Companies Covered in the Report are as follows:

 
• Roche
• LifeScan Inc
• Abbott Diabetes Care
• Arkray
• Ascensia Diabetes Care
• Fora Care
• Entra Health
• Fifty50 Medical
• Infopia
• Genesis Health Technologies
• iHealth Labs
• Oak Tree Health
• Livongo Health
• Nova Diabetes Care
• Sanofi Diabetes
• Telcare
• Walgreens
• U.S. Diagnostics
• Prodigy Diabetes Care
• Omnis Health
"

Companies Mentioned
Roche, LifeScan Inc, Abbott Diabetes Care, Arkray, Ascensia Diabetes Care, Fora Care, Entra Health, Fifty50 Medical, Infopia, Genesis Health Technologies, iHealth Labs, Oak Tree Health, Livongo Health, Nova Diabetes Care, Sanofi Diabetes, Telcare, Walgreens, U.S. Diagnostics, Prodigy Diabetes Care, Omnis Health

Table of Contents
"1. Executive Summary

2. United States Diabetes Population (2011 – 2022): An Analysis
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
2.1.4 Insulin Users

3. United States Blood Glucose Meter Market Analysis (2011–  2022)
3.1 Blood Glucose Meter Users
3.2 Blood Glucose Meter Market

4. Key Drivers and Inhibitors of the United States Blood Glucose Meter Market
4.1 Market Drivers
4.2 Inhibitors

5. United States Blood Glucose Meter Market: Reimbursement & Regulation System
5.1 Reimbursement System
5.2 Regulation System

6. United States Blood Glucose Meter Market – Major Deal Types
6.1 Blood Glucose Meter Market – Collaboration Deals
6.2 Blood Glucose Meter Market – Licensing Agreement
6.3 Blood Glucose Meter Market – Partnership Deals
6.4 Blood Glucose Meter Market – Distribution Agreement
7. Key Companies Analysis
7.1 Roche
7.1.1 Business Overview
7.1.2 Blood Glucose Meter – Marketed Products
7.1.3 Blood Glucose Meter – Latest Development & Trends
7.2 LifeScan Inc
7.2.1 Business Overview
7.2.2 Blood Glucose Meter – Marketed Products
7.2.3 Blood Glucose Meter – Latest Development & Trends
7.3 Abbott Diabetes Care
7.3.1 Business Overview
7.3.2 Blood Glucose Meter – Marketed Products
7.3.3 Blood Glucose Meter – Latest Development & Trends
7.4 Arkray
7.4.1 Business Overview
7.4.2 Blood Glucose Meter – Marketed Products
7.4.3 Blood Glucose Meter – Latest Development & Trends
7.5 Ascensia Diabetes Care
7.5.1 Business Overview
7.5.2 Blood Glucose Meter – Marketed Products
7.5.3 Blood Glucose Meter – Latest Development & Trends
7.6 Fora Care
7.6.1 Business Overview
7.6.2 Blood Glucose Meter – Marketed Products
7.6.3 Blood Glucose Meter – Latest Development & Trends
7.7 Entra Health (Acquired by CRF Health)
7.7.1 Business Overview
7.7.2 Blood Glucose Meter – Marketed Products
7.7.3 Blood Glucose Meter – Latest Development & Trends
7.8 Fifty50 Medical
7.8.1 Business Oveview
7.8.2 Blood Glucose Meter – Marketed Products
7.9 Infopia
7.9.1 Business Ovieview
7.9.2 Blood Glucose Meter – Marketed Products
7.10 Genesis Health Technologies
7.10.1 Business Overview
7.10.2 Blood Glucose Meter – Marketed Products
7.11 iHealth Labs
7.11.1 Business Overview
7.11.2 Blood Glucose Meter – Marketed Products
7.12 Oak Tree Health
7.12.1 Business Overview
7.12.2 Blood Glucose Meter – Marketed Products
7.13 Livongo Health
7.13.1 Business Overview
7.13.2 Blood Glucose Meter – Marketed Products
7.13.3 Blood Glucose Meter - Latest Development & Trends
7.14 Nova Diabetes Care
7.14.1 Business Overview
7.14.2 Blood Glucose Meter – Marketed Products
7.15 Sanofi Diabetes
7.15.1 Business Overview
7.15.2 Blood Glucose Meter – Marketed Products
7.16 Telcare
7.16.1 Business Overview
7.16.2 Blood Glucose Meter – Marketed Products
7.17 Walgreens
7.17.1 Business overview
7.17.2 Blood Glucose Meter – Marketed Products
7.18 U.S. Diagnostics
7.18.1 Business Overview
7.18.2 Blood Glucose Meter – Marketed Products
7.18.3 Blood Glucose Meter – Latest Development & Trends
7.19 Prodigy Diabetes Care
7.19.1 Business Overview
7.19.2 Blood Glucose Meter – Marketed Products
7.19.3 Blood Glucose Meter – Latest Development & Trends
7.20 Omnis Health
7.20.1 Business Overview
7.20.2 Blood Glucose Meter – Marketed Products
7.20.3 Blood Glucose Meter – Latest Development & Trends

"

List of Tables
"List of Tables

Table 4 1: Worldwide – Healthcare Spending on Diabetes (Billion US$), 2015 & 2040

Table 6 1: Collaboration Deals in Blood Glucose Meter Market, 2014 – 2015
Table 6 2: Licensing Agreement in Blood Glucose Meter Market , 2012
Table 6 3: Partnership Deals in Blood Glucose Meter Market, 2009 – 2017
Table 6 4: Distribution Agreement in Blood Glucose Meter Market, 2011 – 2016

Table 7 1: Roche: Blood Glucose Meter Marketed Products
Table 7 2: LifeScan: Blood Glucose Meter Marketed Products
Table 7 3: Abbott Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 4: Arkray: Blood Glucose Meter Marketed Products
Table 7 5: Ascensia Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 6: Fora Care: Blood Glucose Meter Marketed Products
Table 7 7: Entra Health: Blood Glucose Meter Marketed Products
Table 7 8: Fifty50 Medical: Blood Glucose Meter Marketed Products
Table 7 9: Infopia: Blood Glucose Meter Marketed Products
Table 7 10: Genesis Health Technologies: Blood Glucose Meter Marketed Products
Table 7 11: iHealth Labs: Blood Glucose Meter Marketed Products
Table 7 12: Oak Tree Health: Blood Glucose Meter Marketed Products
Table 7 13: Livongo Health: Blood Glucose Meter Marketed Products
Table 7 14: Nova Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 15: Sanofi: Blood Glucose Meter Marketed Products
Table 7 16: Telcare: Blood Glucose Meter Marketed Products
Table 7 17: Walgreens: Blood Glucose Meter Marketed Products
Table 7 18: U.S. Diagnostics: Blood Glucose Meter Marketed Products
Table 7 19: Prodigy Diabetes Care: Blood Glucose Meter Marketed Products
Table 7 20: Omnis Health: Blood Glucose Meter Marketed Products

"


List of Figures
"List of Figures

Figure 2 1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2 2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2 3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2 4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2 5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2 6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2 7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2 8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 2 9: United States – Insulin Users(Thousand),2011 – 2016
Figure 2 10: United States – Forecast for Insulin Users(Thousand),2017 – 2022

Figure 3 1: United States – Blood Glucose Meter Users (Thousand), 2011 – 2016
Figure 3 2: United States – Forecast for Blood Glucose Meter Users (Thousand), 2017 – 2022
Figure 3 3: United States – Blood Glucose Meter Market (Million US$), 2011 – 2016
Figure 3 4: United States – Forecast for Blood Glucose Meter Market (Million US$), 2017 – 2022"

Title Date Price
Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report
By QYResearch
The Europe Digital Camera Head for Endoscopes Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Digital Camera Head for Endoscopes industry. The re ...Read More
Apr 2016 $3600.00
Global Dental Laboratory Handpieces Consumption 2016 Market Research Report
By QYResearch
The Global Dental Laboratory Handpieces Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Dental Laboratory Handpieces market. First, the report ...Read More
Jan 2016 $4000.00
Back to Report Store Home Cardiovascular Disorders Drug Development Pipeline Review, 2017
By GBI Research
Description Cardiovascular disease (CVD) covers a range of difference diseases and conditions affecting the heart and/or blood vessels. The most crucial risk factors for CVD are hypertension and dys ...Read More
Mar 2017 $3995.00
Back to Report Store Home Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes
By GBI Research
Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain ...Read More
Aug 2016 $6995.00
Back to Report Store Home Frontier Pharma: Dermatology - Intracellular Signal Transducers and Cytokine Signaling Molecules Dominate Pipeline and First-in-Class Innovation
By GBI Research
Description Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 distinct dermatological conditions are thought to exist, ranging from rare a ...Read More
Jun 2017 $6995.00
Back to Report Store Home Frontier Pharma: Hematological Disorders - Iron Regulators and Immune Response Targeted Programs Within Anemias and other Red Blood Cell Disorders Hold Potential to Transform Therapy Area with Significant Unmet Need
By GBI Research
The hematological disorders therapy area encompasses non-malignant disorders of the blood such as anemia, sickle cell disease, neutropenia and hemophilia. These diseases can be grouped into the three ...Read More
Aug 2017 $6995.00
Back to Report Store Home Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
By GBI Research
Description Globally, liver cancer is the sixth most common cancer, but its poor prognosis makes it the second leading cause of cancer-related death (Globocan, 2012). Currently, the range of therapi ...Read More
Jun 2017 $6995.00
Back to Report Store Home Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation
By GBI Research
Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a ...Read More
Aug 2016 $6995.00
Back to Report Store Home Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential
By GBI Research
Immunology is a large therapy area characterized by disorders of the immune system – specifically an aberrant immune response against healthy tissues present in the body, leading to chronic or a ...Read More
Jan 2017 $6995.00
Back to Report Store Home Global Immunology Drugs Market to 2022-Increasing Prevalence, Repositioning Opportunities and Strong Uptake of Interleukin Receptor Inhibitors to Drive Growth
By GBI Research
Immunology is a therapy area characterized by disorders of the immune system, specifically an aberrant autoimmune response against healthy tissues in the body, leading to chronic or acute inflammation ...Read More
May 2017 $4995.00

  * Required field
Name *
E-mail *
Telephone 
Company *
Country *
Query 
 
   

Published By :  DPI Research-Marketing Solutions

For support please
contact:
US Toll Free
+1 888-789-6604
Asia Pacific
+91-9893555190
 
 
To receive alerts about
an update, future offers and discounts on this report, signup here.
Email ID
 

Companies


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Countries


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z